4//SEC Filing
Pollard-Knight Denise 4
Accession 0001140361-18-029841
CIK 0001302573other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:09 PM ET
Size
5.4 KB
Accession
0001140361-18-029841
Insider Transaction Report
Form 4
Pollard-Knight Denise
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-22+15,000→ 15,000 totalExercise: $2.55Exp: 2028-06-22→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vests as to 100% of the shares subject thereto upon the earlier of one year following the grant date or the date of the subsequent year's annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeother
Related Parties
1- filerCIK 0001297000
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 6:09 PM ET
- Size
- 5.4 KB